EUVIMEDEUVIMED entdecken
Crossref

ヒト血清アルブミンおよびα1-酸性糖蛋白質の薬物結合サイトに結合するワルファリンとジアゼパムに対する長鎖脂肪酸と中鎖脂肪酸の影響

高村, 徳人, 1013, タカムラ, ノリト, 9000002747919, Takamura, Norito, 1000020369169, 20369169, 緒方, 賢次 und 47 weitere

Kyushu University of Health and Welfare Repository (Kyushu University of Health and Welfare) · 25.03.2024 · 25 · 45-51

DOI: 10.15069/0002000084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kyushu University of Health and Welfare Repository (Kyushu University of Health and Welfare), erschienen am 25.03.2024. Verfasst von 高村 und 58 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study systematically evaluated the effects of long- and medium-chain fatty acids (LFAs and MFAs, respectively) on human serum albumin (HSA) sites I and II and α1-acid glycoprotein (AGP) drug binding sites using warfarin (site I) and diazepam (site II) as probes. Free concentrations of warfarin and diazepam were quantified by UHPLC using ultrafiltration. The results showed that the free fraction of warfarin was lower than that of the control, with increasing [LFAs]/[HSA] (the free fraction of diazepam was markedly higher), whereas the free fraction of warfarin was higher than that of the control, with increasing [LFAs]/[AGP] (the free fraction of diazepam was also similar). In addition, the free fraction of warfarin was slightly higher than that of the control, with increasing [MFAs]/[HSA] (the free fraction of diazepam was markedly higher), and the free fraction of warfarin was slightly higher than that of the control, with increasing [MFAs]/[AGP] (the free fraction of diazepam was also similar). These data suggest that LFAs and MFAs either exert competitive or allosteric inhibition on the binding of warfarin and diazepam to HSA and AGP. However, only LFAs may have a cooperative effect on warfarin binding to HSA.

Schlagwörter

warfarindiazepamhuman serum albuminalpha-1-acid glycoproteinlong-chain fatty acidsmedium-chain fatty acidsdrug binding sitesfree drug fractionallosteric inhibitioncompetitive inhibition

Zitieren

APA

高村, 徳人, 1013, タカムラ, ノリト, 9000002747919, Takamura, Norito, 1000020369169, 20369169, 緒方, 賢次, 1012, オガタ, ケンジ, 9000002747927, Ogata, K., 1000090509580, 90509580, …, & ジュンイチロウ (2024). ヒト血清アルブミンおよびα1-酸性糖蛋白質の薬物結合サイトに結合するワルファリンとジアゼパムに対する長鎖脂肪酸と中鎖脂肪酸の影響. Kyushu University of Health and Welfare Repository (Kyushu University of Health and Welfare), 25, 45-51. https://doi.org/10.15069/0002000084

Vancouver

高村, 徳人, 1013, タカムラ, ノリト, 9000002747919, et al. ヒト血清アルブミンおよびα1-酸性糖蛋白質の薬物結合サイトに結合するワルファリンとジアゼパムに対する長鎖脂肪酸と中鎖脂肪酸の影響. Kyushu University of Health and Welfare Repository (Kyushu University of Health and Welfare). 2024;25:45-51. doi:10.15069/0002000084

BibTeX
@article{2024,
  author = {高村 and 徳人 and 1013 and タカムラ and ノリト and 9000002747919 and Takamura and Norito and 1000020369169 and 20369169 and 緒方 and 賢次 and 1012 and オガタ and ケンジ and 9000002747927 and Ogata, Kenji and 1000090509580 and 90509580 and 石井 and 紗綾 and 7929 and イシイ and サヤ and Ishii and Saya and 尾﨑 and 峯生 and 7928 and オザキ and ミネオ and Ozaki and Mineo and 興梠, 靖幸 and 7885 and コウロギ and ヤスユキ and Kourogi, Yasuyuki and 徳永, 仁 and 1014 and トクナガ and ジン and 9000002747765 and Tokunaga and Jin and 1000060369171 and 60369171 and 山口 and 裕次 and 7956 and ヤマグチ and ユウジ and Yamaguchi and Yuji and 園田 and 純一郎 and 7099 and ソノダ and ジュンイチロウ},
  title = {ヒト血清アルブミンおよびα1-酸性糖蛋白質の薬物結合サイトに結合するワルファリンとジアゼパムに対する長鎖脂肪酸と中鎖脂肪酸の影響},
  journal = {Kyushu University of Health and Welfare Repository (Kyushu University of Health and Welfare)},
  year = {2024},
  volume = {25},
  pages = {45--51},
  doi = {10.15069/0002000084}
}
Kostenlos starten →